Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.88B | 7.04B | 7.18B | 6.94B | 7.24B | 8.66B |
Gross Profit | 5.39B | 5.56B | 5.87B | 5.71B | 6.19B | 7.70B |
EBITDA | 1.14B | 1.25B | 1.38B | 1.55B | 2.09B | 3.15B |
Net Income | 1.76B | 1.79B | 1.94B | 1.94B | 2.56B | 3.28B |
Balance Sheet | ||||||
Total Assets | 29.01B | 30.22B | 30.84B | 29.72B | 28.40B | 23.73B |
Cash, Cash Equivalents and Short-Term Investments | 21.93B | 23.32B | 23.55B | 3.20B | 20.73B | 14.63B |
Total Debt | 0.00 | 96.71M | 196.14M | 110.39M | 124.78M | 202.71M |
Total Liabilities | 3.76B | 5.02B | 5.66B | 588.47M | 4.59B | 4.92B |
Stockholders Equity | 24.00B | 23.95B | 23.93B | 2.35B | 22.75B | 17.63B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.23B | 2.37B | 2.45B | 3.30B | 3.06B |
Operating Cash Flow | 0.00 | 1.37B | 2.45B | 2.57B | 3.52B | 3.33B |
Investing Cash Flow | 0.00 | -3.05B | 1.00B | -3.11B | -3.81B | -2.99B |
Financing Cash Flow | 0.00 | -1.70B | -1.12B | -1.14B | 2.90B | -546.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $3.57B | 16.70 | 6.05% | 6.06% | -7.06% | -20.71% | |
74 Outperform | $3.20B | 26.09 | 29.24% | ― | 4.80% | ― | |
73 Outperform | $1.46B | 22.14 | 9.18% | 4.59% | 26.71% | -23.67% | |
70 Outperform | $1.96B | 14.04 | 20.13% | ― | 5.37% | 13.08% | |
64 Neutral | £1.85B | 8.91 | -12.54% | 3.76% | 1.42% | -47.57% | |
54 Neutral | $165.39M | ― | -23.53% | ― | 11.66% | -4.69% | |
52 Neutral | $236.23M | ― | -12.44% | ― | 8.29% | 87.33% |